전임상 이미징 시장 : 세계 산업 분석, 시장 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for preclinical imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global preclinical imaging market from 2025 to 2032.

Key Insights:

• Preclinical Imaging Market Size (2025E): USD 4.5 Billion
• Projected Market Value (2032F): USD 6.2 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 4.6%

Preclinical Imaging Market - Report Scope:

Preclinical imaging plays a crucial role in drug discovery and biomedical research by enabling non-invasive visualization of biological processes in small animal models. These advanced imaging modalities provide critical insights into disease mechanisms, pharmacokinetics, and treatment efficacy, accelerating the development of new therapies. The preclinical imaging market caters to pharmaceutical and biotechnology companies, research institutes, and academic centers, offering a diverse range of imaging systems, including PET, SPECT, MRI, CT, optical imaging, and ultrasound technologies. Market growth is driven by rising investment in drug development, growing emphasis on personalized medicine, and technological advancements enhancing imaging resolution, sensitivity, and multi-modality capabilities.

Market Growth Drivers:

The global preclinical imaging market is propelled by several key factors, including increasing R&D expenditure in pharmaceutical and biotechnology sectors, fueling demand for precise and high-throughput imaging solutions to evaluate new drug candidates. The growing focus on oncology and neurological research significantly contributes to the adoption of advanced imaging systems for early disease detection and treatment monitoring. Technological innovations, such as hybrid imaging systems combining PET/MRI or PET/CT, offer improved anatomical and functional insights, fostering market expansion. Furthermore, government initiatives supporting preclinical research and collaborations between industry and academia strengthen market growth prospects.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces challenges related to high costs associated with sophisticated imaging equipment and maintenance, which can limit adoption among smaller research facilities and academic institutions. Stringent regulatory guidelines and ethical considerations surrounding animal research impose additional operational complexities and compliance burdens on market players. Moreover, the availability of alternative in-vitro testing methods and computational models for drug screening may pose competition to traditional preclinical imaging studies, particularly for certain applications. Addressing cost and ethical barriers requires innovative business models, technological advancements to reduce system costs, and continued advocacy for the value of in-vivo imaging in translational research.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by emerging applications in immuno-oncology, regenerative medicine, and molecular imaging research. Advances in imaging probes and contrast agents enable precise targeting and visualization of specific molecular pathways, expanding the utility of preclinical imaging in drug discovery and biomarker validation. Additionally, the integration of artificial intelligence and machine learning into image analysis enhances data interpretation, improves workflow efficiency, and accelerates research timelines. Strategic collaborations, investments in hybrid imaging modalities, and development of cost-effective and user-friendly imaging systems are crucial to capitalizing on these opportunities and maintaining market leadership in the evolving preclinical research landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the preclinical imaging market globally?
• Which imaging modalities and applications are driving preclinical imaging adoption across research settings?
• How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
• Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop advanced imaging platforms, including hybrid systems and high-resolution imaging technologies, addressing diverse research requirements in oncology, cardiology, and neurology. Collaborations with academic institutions, pharmaceutical companies, and government research agencies facilitate technology adoption and market expansion. Moreover, emphasis on user-friendly software solutions, enhanced imaging probes, and comprehensive customer support services fosters market growth and strengthens competitive positioning in the rapidly advancing preclinical imaging sector.

Key Companies Profiled:

• Bruker
• Siemens Healthcare Private Limited
• Revvity
• FUJIFILM VisualSonics, Inc.
• Scintica
• MILabs B.V.
• United Imaging Healthcare Co., Ltd.
• Mediso Ltd.
• Aspect Imaging Ltd.
• Inviscan Imaging Systems
• TriFoil Imaging
• Southern Scientific Ltd.
• Iconeus
• MR Solutions
• BioPAL, Inc.
• Viscover

Preclinical Imaging Market Research Segmentation:

The preclinical imaging market encompasses a diverse range of technologies, applications, and end-user segments, addressing various research needs and disease models.

By Product

• Imaging Systems
• Reagents
• Software and Services

By Modality

• Optical Imaging
• Nuclear Molecular Imaging
• Micro MRI
• Micro Ultrasound
• Micro CT
• Photoacoustic Tomography (PAT)
• Magnetic Particle Imaging
• Others

By Application

• Research & Development
• Drug Discovery & Development

By End-user

• Pharmaceutical and Biotech Companies
• Academic and Research Institutes
• Imaging Centers
• Others

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Preclinical Imaging Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product
• 4.4. Regional Prices and Product Preferences

5. Global Preclinical Imaging Market Outlook

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Bn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 5.3. Global Preclinical Imaging Market Outlook: Product
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2024
  • 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 5.3.3.1. Imaging Systems
    • 5.3.3.2. Reagents
    • 5.3.3.3. Software & Services
  • 5.3.4. Market Attractiveness Analysis: Product
• 5.4. Global Preclinical Imaging Market Outlook: Modality
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
  • 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 5.4.3.1. Optical Imaging
    • 5.4.3.2. Nuclear Molecular Imaging
    • 5.4.3.3. Micro MRI
    • 5.4.3.4. Micro Ultrasound
    • 5.4.3.5. Micro CT
    • 5.4.3.6. Photoacoustic Tomography (PAT)
    • 5.4.3.7. Magnetic Particle Imaging
    • 5.4.3.8. Others
  • 5.4.4. Market Attractiveness Analysis: Modality
• 5.5. Global Preclinical Imaging Market Outlook: Application
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
  • 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 5.5.3.1. Research & Development
    • 5.5.3.2. Drug Discovery & Development
  • 5.5.4. Market Attractiveness Analysis: Application
• 5.6. Global Preclinical Imaging Market Outlook: End User
  • 5.6.1. Introduction / Key Findings
  • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
  • 5.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 5.6.3.1. Pharmaceutical and Biotech Companies
    • 5.6.3.2. Academic and Research Institutes
    • 5.6.3.3. Imaging Centers
    • 5.6.3.4. Others
  • 5.6.4. Market Attractiveness Analysis: End User

6. Global Preclinical Imaging Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 6.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Modality
  • 7.2.4. By Application
  • 7.2.5. By End User
• 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 7.4.1. Imaging Systems
  • 7.4.2. Reagents
  • 7.4.3. Software & Services
• 7.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 7.5.1. Optical Imaging
  • 7.5.2. Nuclear Molecular Imaging
  • 7.5.3. Micro MRI
  • 7.5.4. Micro Ultrasound
  • 7.5.5. Micro CT
  • 7.5.6. Photoacoustic Tomography (PAT)
  • 7.5.7. Magnetic Particle Imaging
  • 7.5.8. Others
• 7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Research & Development
  • 7.6.2. Drug Discovery & Development
• 7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 7.7.1. Pharmaceutical and Biotech Companies
  • 7.7.2. Academic and Research Institutes
  • 7.7.3. Imaging Centers
  • 7.7.4. Others
• 7.8. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Modality
  • 8.2.4. By Application
  • 8.2.5. By End User
• 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 8.4.1. Imaging Systems
  • 8.4.2. Reagents
  • 8.4.3. Software & Services
• 8.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 8.5.1. Optical Imaging
  • 8.5.2. Nuclear Molecular Imaging
  • 8.5.3. Micro MRI
  • 8.5.4. Micro Ultrasound
  • 8.5.5. Micro CT
  • 8.5.6. Photoacoustic Tomography (PAT)
  • 8.5.7. Magnetic Particle Imaging
  • 8.5.8. Others
• 8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Research & Development
  • 8.6.2. Drug Discovery & Development
• 8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 8.7.1. Pharmaceutical and Biotech Companies
  • 8.7.2. Academic and Research Institutes
  • 8.7.3. Imaging Centers
  • 8.7.4. Others
• 8.8. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Modality
  • 9.2.4. By Application
  • 9.2.5. By End User
• 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 9.4.1. Imaging Systems
  • 9.4.2. Reagents
  • 9.4.3. Software & Services
• 9.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 9.5.1. Optical Imaging
  • 9.5.2. Nuclear Molecular Imaging
  • 9.5.3. Micro MRI
  • 9.5.4. Micro Ultrasound
  • 9.5.5. Micro CT
  • 9.5.6. Photoacoustic Tomography (PAT)
  • 9.5.7. Magnetic Particle Imaging
  • 9.5.8. Others
• 9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Research & Development
  • 9.6.2. Drug Discovery & Development
• 9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 9.7.1. Pharmaceutical and Biotech Companies
  • 9.7.2. Academic and Research Institutes
  • 9.7.3. Imaging Centers
  • 9.7.4. Others
• 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Modality
  • 10.2.4. By Application
  • 10.2.5. By End User
• 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 10.4.1. Imaging Systems
  • 10.4.2. Reagents
  • 10.4.3. Software & Services
• 10.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 10.5.1. Optical Imaging
  • 10.5.2. Nuclear Molecular Imaging
  • 10.5.3. Micro MRI
  • 10.5.4. Micro Ultrasound
  • 10.5.5. Micro CT
  • 10.5.6. Photoacoustic Tomography (PAT)
  • 10.5.7. Magnetic Particle Imaging
  • 10.5.8. Others
• 10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Research & Development
  • 10.6.2. Drug Discovery & Development
• 10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 10.7.1. Pharmaceutical and Biotech Companies
  • 10.7.2. Academic and Research Institutes
  • 10.7.3. Imaging Centers
  • 10.7.4. Others
• 10.8. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Modality
  • 11.2.4. By Application
  • 11.2.5. By End User
• 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 11.4.1. Imaging Systems
  • 11.4.2. Reagents
  • 11.4.3. Software & Services
• 11.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 11.5.1. Optical Imaging
  • 11.5.2. Nuclear Molecular Imaging
  • 11.5.3. Micro MRI
  • 11.5.4. Micro Ultrasound
  • 11.5.5. Micro CT
  • 11.5.6. Photoacoustic Tomography (PAT)
  • 11.5.7. Magnetic Particle Imaging
  • 11.5.8. Others
• 11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Research & Development
  • 11.6.2. Drug Discovery & Development
• 11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 11.7.1. Pharmaceutical and Biotech Companies
  • 11.7.2. Academic and Research Institutes
  • 11.7.3. Imaging Centers
  • 11.7.4. Others
• 11.8. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Market Outlook

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Product
  • 12.2.3. By Modality
  • 12.2.4. By Application
  • 12.2.5. By End User
• 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 12.4.1. Imaging Systems
  • 12.4.2. Reagents
  • 12.4.3. Software & Services
• 12.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 12.5.1. Optical Imaging
  • 12.5.2. Nuclear Molecular Imaging
  • 12.5.3. Micro MRI
  • 12.5.4. Micro Ultrasound
  • 12.5.5. Micro CT
  • 12.5.6. Photoacoustic Tomography (PAT)
  • 12.5.7. Magnetic Particle Imaging
  • 12.5.8. Others
• 12.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 12.6.1. Research & Development
  • 12.6.2. Drug Discovery & Development
• 12.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 12.7.1. Pharmaceutical and Biotech Companies
  • 12.7.2. Academic and Research Institutes
  • 12.7.3. Imaging Centers
  • 12.7.4. Others
• 12.8. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Bruker
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Product
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Siemens Healthcare Private Limited
  • 13.3.3. Revvity
  • 13.3.4. FUJIFILM VisualSonics, Inc.
  • 13.3.5. Scintica
  • 13.3.6. MILabs B.V.
  • 13.3.7. United Imaging Healthcare Co., Ltd.
  • 13.3.8. Mediso Ltd.
  • 13.3.9. Aspect Imaging Ltd.
  • 13.3.10. Inviscan Imaging Systems
  • 13.3.11. TriFoil Imaging
  • 13.3.12. Southern Scientific Ltd.
  • 13.3.13. Iconeus
  • 13.3.14. MR Solutions
  • 13.3.15. BioPAL, Inc.
  • 13.3.16. Viscover

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations